-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q2 2024.
- SAB Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $246K, a 108% increase year-over-year.
- SAB Biotherapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $841K, a 3.06% increase year-over-year.
- SAB Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $600K, a 50% decline from 2022.
- SAB Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $1.2M, a 4.62% increase from 2021.
- SAB Biotherapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.15M, a 103% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)